Prostate ultrasound: back in business!

Abstract

The use of grey scale prostate ultrasound decreased after the implementation of magnetic resonance imaging (MRI) for thediagnosis and evaluation of prostate cancer. The new developments, such as multiparametric ultrasound and MRI-ultrasoundfusion technology, renewed the interest for this imaging method in the assessment of prostate cancer. The purpose of this paperwas to review the current role of prostate ultrasound in the setting of these new applications. A thorough reevaluation of theselection criteria of the patients is required to assess which patients would benefit from multiparametric ultrasound, who wouldbenefit from multiparametric MRI or the combination of both to assist prostate biopsy in order to ensure the balance betweenoverdiagnosis and underdiagnosis of prostate cancer.